Candida (Candi) Braithwaite is the Managing Director of Biopharmax Pte Limited, a Singapore based consultancy supporting organisations in the biopharmaceutical and life science sector with commercialisation and business development expertise since 2015. She has worked with start-ups, SMEs, universities, and government institutions in the region on pharmaceuticals and health technology projects. Current projects include a novel technology for better t-cell specific therapies for cancer and autoimmune disease.

Prior to Biopharmax, she held senior executive roles at some of the world’s largest pharmaceutical companies including Shire and Wyeth/Pfizer in Australia and USA. She also is an experienced coach with an excellent reputation for the development of both teams and individuals.